Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRX-I vs Linezolid in ABSSSI
NCT02269319Phase 2Completed
- Sponsor
- MicuRx Pharmaceuticals
- Start
- Feb 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of contezolid in acute bacterial skin and skin structure infection (ABSSSI), sponsored by MicuRx Pharmaceuticals. Started Feb 2015; status: completed.
02
Drugs
contezolid
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT02269319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269319.